CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

After underperforming throughout 2024, shares of CVS Health (NYSE: CVS) are surging. From the end of 2024 through Feb. 14, ...

CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS ...

CVS Health downgraded to Hold due to political risks, declining cash flow, and industry battles despite strong Q4 sales and a ...

CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...

Wall Street appears to like CVS (CVS) CEO David Joyner's conservative approach to the company's 2025 financial outlook, rewarding the stock with a nearly 15% bump by market close Wednesday.